中文版
Anti-Diabetic
Cagrilintide
Catalog No. :
CLP1113
Product Name :
Cagrilintide
CAS No. :
1415456-99-3
Synonyms :
Chemical Name :
Sequence {Eicosanedioic acid-γ-Glu}-Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Glu-Phe-Leu-Arg-His-Ser-Ser-Asn-Asn-Phe-Gly-Pro-Ile-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Pro-NH2 (Disulfide bridge:Cys3-Cys8)
Molecular Formula :
C194H312N54O59S2
Molecular Weight :
4409.01
Molecular Structure :
Appearance :
White to off-white powder
Specification :
98+%
Application :
Research on the treatment of diabetes | CGRP Receptor
Registration :
Storage Condition :
Dry, dark and at -20 ℃ for 1 year or -80 ℃ for 2 years

Cagrilintide, an investigational novel long-acting acylated amylin analogue, functions as an agonist for nonselective amylin receptors (AMYR) and the calcitonin G protein-coupled receptor (CTR). It significantly reduces food intake and induces weight loss, showing promise for obesity research.


Statement:
->>Products covered by valid patents are not offered or supplied for commercial use.
->>Products currently covered by valid US Patents are offered for laboratory R&D use in accordance with 35 USC 271(e)+A13(1).
->>Any patent infringement and resulting liability is solely at buyer's risk.
->>Our products are only raw materials for drugs or industry, can't be used for human or animals directly.

  • Cagrilintide, an investigational novel long-acting acylated amylin analogue, functions as an agonist for nonselective amylin receptors (AMYR) and the calcitonin G protein-coupled receptor (CTR). It significantly reduces food intake and induces weight loss, showing promise for obesity research.


  • PPAR agonist 1

    Insulin Aspart

    Insulin Degludec

    Semaglutide

Request A Quote
Your Name(required)
Email(required)
Product Name(required)
Country or Region(required)
Organization Name(required)
Messages(required)
Captcha(required)
Sending...